- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova
- Culegere de postere
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/12856
Title: | The role of metalloproteinases (MMPs) in tumor development |
Authors: | Spoială, Augustina |
Keywords: | metalloproteases;ADAM;ADAMTS;cancer;matrix metalloproteases |
Issue Date: | Oct-2020 |
Publisher: | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova |
Abstract: | Introduction: MMPs are a family of
proteinases that regulate cell behavior by
remodeling stromal and cell surface
proteins, thereby influencing cell survival,
genomic stability, and differentiation.
MMPs are key players in the neoplastic
cells’ development and dissemination.
Material and methods: In order to achieve
the proposed goal, the publications from
the specialized journals of the PubMed,
Medline and Hinari electronic libraries
have been examined.
Purpose: To summarize the evidence
derived from international studies on
expression and involvement of
metalloproteinases in the tumor growth,
invasion, migration and angiogenesis to
identify potential therapeutic strategies.
Results: A positive correlation between tumor
progression and the expression of multiple MMPs in
tumor tissues has been demonstrated. There are
many reports showing that members of the ADAM
family are overexpressed in human cancers.
Protumor activities have also been reported for
ADAMTS-1 in mammary carcinomas, ADAMTS-12
in breast cancer cells, ADAMTS-4 and ADAMTS-5
in glioblastoma. Other ADAMTS metalloproteases
showing tumor-associated effects are ADAMTS-2,
ADAMTS-14 and ADAMTS-18.
Conclusions:Altered expression of MMPs,
ADAMs and ADAMTSs has been found in
diverse tumor types. However, the exact
role of these proteinases in the initiation or
progression of the disease is generally still
poorly elucidated. Specific inhibitors of
ADAM could be potential remedies in anticancer
therapy. |
URI: | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii http://repository.usmf.md/handle/20.500.12710/12856 |
Appears in Collections: | Culegere de postere
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|